Drug Shortage Report for EMEND IV
| Report ID | 144168 |
| Drug Identification Number | 02363356 |
| Brand name | EMEND IV |
| Common or Proper name | fosaprepitant for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FOSAPREPITANT |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 150MG 1DOSE LOW EDTA VIAL |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-08-27 |
| Actual start date | 2021-08-27 |
| Estimated end date | 2021-09-03 |
| Actual end date | 2021-08-30 |
| Shortage status | Resolved |
| Updated date | 2021-08-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-08-31 | French | Compare |
| v7 | 2021-08-30 | French | Compare |
| v6 | 2021-08-30 | English | Compare |
| v5 | 2021-08-28 | English | Compare |
| v4 | 2021-08-27 | English | Compare |
| v3 | 2021-08-16 | French | Compare |
| v2 | 2021-08-16 | English | Compare |
| v1 | 2021-08-16 | English | Compare |
Showing 1 to 8 of 8